Carregant...
Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1
The metabolic syndrome covers metabolic abnormalities including obesity and type 2 diabetes (T2D). T2D is characterized by insulin resistance resulting from both environmental and genetic factors. A genome-wide association study (GWAS) published in 2010 identified TP53INP1 as a new T2D susceptibilit...
Guardat en:
Publicat a: | EMBO Mol Med |
---|---|
Autors principals: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
BlackWell Publishing Ltd
2015
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4459819/ https://ncbi.nlm.nih.gov/pubmed/25828351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201404318 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|